HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

Authors :: A. Elisa Pasqua
Swee Y. Sharp
Nicola E. A. Chessum
Angela Hayes
Loredana Pellegrino
Michael J. Tucker
Asadh Miah
Birgit Wilding
Lindsay E. Evans
Carl S. Rye
N. Yi Mok
Manjuan Liu
Alan T. Henley
Sharon Gowan
Emmanuel De Billy
Robert te Poele
Marissa Powers
Suzanne A. Eccles
Paul A. Clarke
Florence I. Raynaud
Paul Workman
Keith Jones
Matthew D. Cheeseman
Source :: Journal of Medicinal Chemistry. 66:5907-5936
Publication Year :: 2023
Publisher :: American Chemical Society (ACS), 2023.

Tools